The number of cases will increase, but the rates seem to be declining with every birth cohort that reaches advanced ages, ...
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
Alzheimer's Disease can seem like a tragic inevitability for those who have rare genetic forms of the disease. The ...
But a new study looking at the anti-amyloid drug gantenerumab could change all that. Published in the Lancet Neurology ...
Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...
Kitty Dukakis, former Massachusetts first lady and mental health advocate, died at 88. She battled alcoholism and depression, ...
In a major Phase 3 clinical trial, lecanemab showed it could slow the decline in memory and thinking ability by 27% overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results